Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Osteosarcoma × cabozantinib × Clear all

Phase

Status

Recruiting 5 Active not recruiting 2 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 5 Carcinoma, Renal Cell 5 Brain Neoplasms 3 Neoplasm Metastasis 2 Multiple Myeloma 2 Melanoma 2 Kidney Neoplasms 2 Glioma 2 Glioblastoma 2 Carcinoma, Transitional Cell 2 Carcinoma, Non-Small-Cell Lung 2 Astrocytoma 2 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Thyroid cancer, medullary 1 Thyroid Neoplasms 1 Thyroid Diseases 1 Thyroid Cancer, Papillary 1 Thrombocytosis 1 Skin Neoplasms 1 Salivary Gland Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Pain 1 Osteosarcoma 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1

Interventions

Ifosfamide 6 Leucovorin 5 Doxorubicin 4 Dexrazoxane 4 Cisplatin 4 Methotrexate 3 Filgrastim 3 Carboplatin 3 mifamurtide 2 glucarpidase 2 Radiotherapy 2 Neoadjuvant Therapy 2 Mesna 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Granulocyte Colony-Stimulating Factor 2 Gemcitabine 2 Cryosurgery 2 Chemotherapy, Adjuvant 2 temsirolimus 1 sintilimab 1 sargramostim 1 saracatinib 1 samarium Sm-153 lexidronam 1 robatumumab 1 pembrolizumab 1 pegfilgrastim 1 pazopanib 1 omburtamab I-131 1 niraparib 1 lexatumumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06341712 2026-03-31

CabOSTar

Ipsen

Phase 2 Terminated

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡